share_log

Piper Sandler Maintains Neutral on Edwards Lifesciences, Raises Price Target to $88

Benzinga ·  Apr 26 10:26

Piper Sandler analyst Adam Maeder maintains Edwards Lifesciences (NYSE:EW) with a Neutral and raises the price target from $85 to $88.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment